TrialAnnals of surgical oncology2017

Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping.

Pat Whitworth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.